F.B.I. agents thought they had weakened an online hate group known as the Base. A string of European terrorism cases ...

Gilead Sciences (GILD) on Monday said it would acquire privately held Ouro Medicines, a biotech company developing T cell engager therapies for autoimmune diseases. The agreement includes $1.675 ...

Lymph nodes are key control centers in the immune system and play an important role in defending the body against infections ...

CDR111, an experimental MS therapy designed to eliminate harmful B-cells, reached an early development milestone.

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

When a virus enters the lungs, the immune system has to react fast. The lung maintains its own community of immune cells ...

For decades, cancer immunotherapy has focused primarily on CD8+ cytotoxic T lymphocytes as the main executors of tumor cell ...

A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer ...

Johns Hopkins Medicine scientists say they have developed a simplified version of biodegradable nanoparticles that can ...